Three rounds of financing a year ranks at the forefront of the medical AI track, and Keya Medical receives more than 200 million C rounds of financing

pays attention to SynTao Ventures.com, and don’t get lost on the venture capital road

SynTao Ventures.com 11 month 11 The official learned: Keyya Medical is a developer and service provider focusing on medical artificial intelligence applications. Recently announced the completion of more than 200 million yuan C round of financing. This is also the third round of financing completed by Keya’s Ark within 9 months of this year. This round of financing is led by IDG Capital, and is jointly invested by Source Code Capital and Tasly. The original shareholder Yahui Capital continued to follow suit.

Keya Medical: A precision medical diagnosis platform based on medical imaging and artificial intelligence

SynTao Ventures.com reported in August that Keya Medical, which received a billion-dollar financing. Keya Medical is a developer and service provider of medical artificial intelligence applications. Artificial intelligence technology helps the implementation of smart medical care and adheres to the concept of "artificial intelligence leading smart medical care". At this stage, Keya’s R&D has formed four series of "vascular disease precision diagnosis and treatment product series, tumor disease precision diagnosis and treatment product series, imaging department intelligent diagnosis and treatment product series, and AI medical service products", with more than ten products.

Keya Medical has a strong R&D team of more than 100 people, with rich experience in AI technology, image analysis and medical big data. In addition, Keya Medical actively develops scientific research cooperation with domestic and foreign hospitals. At present, Keya Medical has realized the application of products in more than 30 provinces across the country, and more than 300 large-scale tertiary hospitals have participated in the cooperation, covering more than 20 million patients.

reviews the financing history of Keya Medical: it received tens of millions of dollars in angel round financing from Guangxin Capital and Kunlun Wanwei in 2019; in February 2020, it obtained old shareholders Kunlun Wanwei, IDG Capital, Shanghai Guofang’s parent fund and Yahui Capital’s 100 million yuan A round of financing; July, completed B round financing, invested by Amber Capital; August, received 150 million yuan of B+ round financing, jointly invested by GGV Jiyuan Capital and Yahui Capital, the original shareholder Fund of funds and Kunlun Wanwei continued to invest.

What is the next step of Keyya Medical, the financing party? The relevant person in charge of

Keya Medical said: This round of financing will continue to support its business expansion in the AI ​​medical field and global market coverage, further consolidate the industrialization and commercialization of the existing product line, and will also Reserve power for the development and promotion of new product lines, and accelerate the construction of a more complete product layout with a wider coverage of clinical pathways.

What is the reason for the investment of Kunlun Wanwei? The relevant person in charge of

investor Kunlun Wanwei said: Investing in Keya Medical is an important measure for the company to practice its core Internet business, investing in the Internet of Things and artificial intelligence development strategy, based on Keya Medical’s leading technological advantages and stable and powerful core The technical team injects strong and lasting impetus into the company's long-term development. This investment in AI+Medical Science and Technology has made the wings of Kunlun Wanwei AI+ Matrix more plump.

How does SynTao Venture Partners comment on this financing event? Viewpoints of Wang Shuai, founder of

SynTao Ventures: Keya Medical has completed three large-scale financings in nine months this year, with a cumulative amount of more than 500 million yuan. The market value scale is in the leading position in the industry, and the results are very impressive. It is believed that with the support of capital and the framework of leading technology and team, Keya Medical can grow into a leading company in artificial intelligence medical care.

original author: Zheng Tong

official review: Zofia

Published: November 11 2020

copyright attribution: Road to Venture Network | a venture capital circle ecological service providers have a sense of national identity, is committed to the prosperity of the Chinese venture capital circles Work hard for development!